Pharmagest Interactive SA
Pharmagest Interactive SA PHA.PA Peers
See (PHA.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHA.PA | €84.50 | N/A | 0 | 32.75 | €2.58 | N/A |
| EQS.PA | €50.10 | -1.57% | 753.1M | 16.06 | €3.12 | +2.50% |
| CGM.PA | €10.85 | -1.36% | 148.8M | -9.86 | -€1.10 | N/A |
| ALINS.PA | €0.31 | +6.16% | 16.3M | -2.82 | -€0.11 | N/A |
| ALAMA.PA | €0.27 | -1.10% | 14.4M | -1.35 | -€0.20 | N/A |
| MLLAB.PA | €2.22 | N/A | 5.3M | 55.50 | €0.04 | +9.22% |
| SDT.PA | €3.00 | N/A | 0 | 14.35 | €0.21 | N/A |
Stock Comparison
PHA.PA vs EQS.PA Comparison
PHA.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHA.PA stands at 0. In comparison, EQS.PA has a market cap of 753.1M. Regarding current trading prices, PHA.PA is priced at €84.50, while EQS.PA trades at €50.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHA.PA currently has a P/E ratio of 32.75, whereas EQS.PA's P/E ratio is 16.06. In terms of profitability, PHA.PA's ROE is +0.27%, compared to EQS.PA's ROE of +0.16%. Regarding short-term risk, PHA.PA is less volatile compared to EQS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for PHA.PA.